Therapeutic Asset Ratings

705 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Evomela Hereditary Persistence Of Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela B-Lymphoblastic Leukemia/Lymphoma With IAMP21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela Monosomy 7 Myelodysplasia And Leukemia Syndrome 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela Neurofibromatosis Type 1	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela NF1 Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela T Cell Receptor Alpha/Beta Depletion	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Evomela Li-Fraumeni Syndrome	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Autologous Stem Cell Transplant	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM CBL Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Chromosome Abnormality	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM CNS Leukemia	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Fetal Hemoglobin	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Intrachromosomal Amplification of Chromosome 21	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Monosomy 7	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM NF1 Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM N-RAS Gene Amplification	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM PTPN11 Gene Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Remission	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM Somatic Mutation	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM T Cell Receptor Alpha/Beta Depletion	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
FILGRASTIM TP53	Masonic Cancer Center, University of Minnesota	P2	CCC (53)
Fludarabine Acyl-CoA Oxidase Deficiency	Masonic Cancer Center, University of Minnesota	P2	CCC (53)

Showing 326 to 350 of 705 assets

PreviousPage 14 of 29Next